1. Scrip
  2. >>Archive

Competence And Fairness At One Of Europe’s Dynamic API Producers

Don’t miss an inside look at how CF Pharma and its subsidiary, Pátriapharma, have successfully leveraged innovation and a focus on competence and fairness to be a leading CMO and generic API producer. Discover how CF Pharma has come to stand for “competent and fair” in the company’s approach to its business practices, products, and people.

Competence And Fairness At One Of Europe’s Dynamic API Producers | pdf

Don’t miss your free article from Pharma Ignite, presented in partnership with CF Pharma.

Read this article and learn how CF Pharma:

  • Is effectively addressing API supply chain issues
  • Embraces innovative solutions as part of their environmental, social, and governance (ESG) philosophy
  • Emphasizes safety and sustainability as part of their processes
  • Maintains a focus on a culture of quality
  • Innovates within their R&D teams
  • Has recently moved into providing intermediates

More from Archive

Final Chance To Have Your Say: Take Scrip's Reader Survey This Week

 
• By Eleanor Malone

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By Eleanor Malone

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in the coverage topics, content format or the method in which you receive and access Scrip, or if you love it how it is, now is the time to have your voice heard.

Galapagos Expands Point-Of-Care CAR-T Study To The US

 
• By Andrew McConaghie

CEO Paul Stoffels said gaining US clearance for an IND for its novel CAR-T product was demanding, but now opens up a pathway towards a pivotal study starting in 2025.

Analysts Split On Eisai’s Chances Of Changing EU Regulator’s Mind On Leqembi

 
• By Andrew McConaghie

A final rejection of Leqembi could also spell the same fate for Lilly’s rival drug but public outcry and demand for Alzheimer’s therapies might force the regulator’s hand

More from Scrip

Sponsored by

The British Pharmacopoeia: Setting standards that are trusted worldwide

In this exclusive article with Peter Crowley, Secretary and Scientific Director of the BP Commission, you’ll discover how the BP is preparing for its landmark 2026 edition while strengthening its influence as a global bridge between science, regulation, and industry.

In Partnership with FDA

CDER Center for Clinical Trial Innovation (C3TI)

Discover how FDA’s C3TI is advancing clinical trials and creating new opportunities to shape the future of drug development.

In Partnership with FDA

CDER Center for Clinical Trial Innovation (C3TI)

Discover how FDA’s C3TI is advancing clinical trials and creating new opportunities to shape the future of drug development.

Sponsored by:

Neurodiversity in the Workplace

Neurodiversity in the workplace reflects varied cognitive profiles, including conditions like autism, ADHD, and dyslexia. Aspire Pharma outlines steps to support neurodivergent employees, such as flexible work, clear communication, training for manager, and employee-led groups that promote inclusion